Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health

Ran Yin, Hsiao Chen Kuo, Rasika Hudlikar, Davit Sargsyan, Shanyi Li, Lujing Wang, Renyi Wu, Ah-Ng Kong

Research output: Contribution to journalReview article

Abstract

Purpose of Review: In this review, we discuss the roles of the gut microbiota and dietary phytochemicals in improving human health. Recent studies have reported that the human gut microbiota can be altered by dietary phytochemicals, including phenolics, carotenoids, and dietary fibers. In addition, both pathogenic and nonpathogenic bacteria show regulatory effects with phytochemicals, suggesting potential synergistic effects in the improvement of human gut health and prevention of chronic diseases. Recent Findings: Numerous studies have been conducted on gut microbial alterations induced by phytochemicals, such as phenolics and carotenoids. Butyrate, a short-chain fatty acid produced via bacterial fermentation in the colon, also shows a significantly beneficial effect in the maintenance of gut microbial homeostasis. However, the molecular mechanisms underlying the effects of diets and the interactions of the gut microorganisms remain poorly understood. The gut microbiome profile changes have been observed in chronic inflammation-induced diseases, including colitis, Crohn’s disease, immune dysfunction, colon cancer, obesity, and diabetes. The anti-inflammatory effects of dietary phytochemicals against these diseases may be partially mediated by the regulation of microbial profiles. The latest advances in biomedical technology, such as next-generation sequencing (NGS), and continuous cost reduction associated with these technologies have enabled researchers to perform an ever-increasing number of large-scale, high-throughput computational analyses to elucidate the potential mechanism of phytochemical–microbiome interactions. Summary: Information obtained from these studies may provide valuable insights to guide future clinical research for the development of therapeutics, botanicals, and drug efficacy testing, many of which will be discussed in this review.

Original languageEnglish (US)
Pages (from-to)332-344
Number of pages13
JournalCurrent Pharmacology Reports
Volume5
Issue number5
DOIs
StatePublished - Oct 1 2019

Fingerprint

Phytochemicals
Health
Carotenoids
Biomedical Technology
Volatile Fatty Acids
Butyrates
Dietary Fiber
Colitis
Nutrition
Medical problems
Cost reduction
Crohn Disease
Microorganisms
Colonic Neoplasms
Fermentation
Bacteria
Colon
Homeostasis
Chronic Disease
Anti-Inflammatory Agents

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Genetics
  • Pharmacology
  • Drug Discovery

Keywords

  • Chronic diseases
  • Human health
  • Microbiota
  • Phytochemicals

Cite this

Yin, Ran ; Kuo, Hsiao Chen ; Hudlikar, Rasika ; Sargsyan, Davit ; Li, Shanyi ; Wang, Lujing ; Wu, Renyi ; Kong, Ah-Ng. / Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health. In: Current Pharmacology Reports. 2019 ; Vol. 5, No. 5. pp. 332-344.
@article{8243e4a894a343f9b823c5856fe0a2f7,
title = "Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health",
abstract = "Purpose of Review: In this review, we discuss the roles of the gut microbiota and dietary phytochemicals in improving human health. Recent studies have reported that the human gut microbiota can be altered by dietary phytochemicals, including phenolics, carotenoids, and dietary fibers. In addition, both pathogenic and nonpathogenic bacteria show regulatory effects with phytochemicals, suggesting potential synergistic effects in the improvement of human gut health and prevention of chronic diseases. Recent Findings: Numerous studies have been conducted on gut microbial alterations induced by phytochemicals, such as phenolics and carotenoids. Butyrate, a short-chain fatty acid produced via bacterial fermentation in the colon, also shows a significantly beneficial effect in the maintenance of gut microbial homeostasis. However, the molecular mechanisms underlying the effects of diets and the interactions of the gut microorganisms remain poorly understood. The gut microbiome profile changes have been observed in chronic inflammation-induced diseases, including colitis, Crohn’s disease, immune dysfunction, colon cancer, obesity, and diabetes. The anti-inflammatory effects of dietary phytochemicals against these diseases may be partially mediated by the regulation of microbial profiles. The latest advances in biomedical technology, such as next-generation sequencing (NGS), and continuous cost reduction associated with these technologies have enabled researchers to perform an ever-increasing number of large-scale, high-throughput computational analyses to elucidate the potential mechanism of phytochemical–microbiome interactions. Summary: Information obtained from these studies may provide valuable insights to guide future clinical research for the development of therapeutics, botanicals, and drug efficacy testing, many of which will be discussed in this review.",
keywords = "Chronic diseases, Human health, Microbiota, Phytochemicals",
author = "Ran Yin and Kuo, {Hsiao Chen} and Rasika Hudlikar and Davit Sargsyan and Shanyi Li and Lujing Wang and Renyi Wu and Ah-Ng Kong",
year = "2019",
month = "10",
day = "1",
doi = "10.1007/s40495-019-00196-3",
language = "English (US)",
volume = "5",
pages = "332--344",
journal = "Current Pharmacology Reports",
issn = "2198-641X",
publisher = "Springer International Publishing AG",
number = "5",

}

Yin, R, Kuo, HC, Hudlikar, R, Sargsyan, D, Li, S, Wang, L, Wu, R & Kong, A-N 2019, 'Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health', Current Pharmacology Reports, vol. 5, no. 5, pp. 332-344. https://doi.org/10.1007/s40495-019-00196-3

Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health. / Yin, Ran; Kuo, Hsiao Chen; Hudlikar, Rasika; Sargsyan, Davit; Li, Shanyi; Wang, Lujing; Wu, Renyi; Kong, Ah-Ng.

In: Current Pharmacology Reports, Vol. 5, No. 5, 01.10.2019, p. 332-344.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health

AU - Yin, Ran

AU - Kuo, Hsiao Chen

AU - Hudlikar, Rasika

AU - Sargsyan, Davit

AU - Li, Shanyi

AU - Wang, Lujing

AU - Wu, Renyi

AU - Kong, Ah-Ng

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Purpose of Review: In this review, we discuss the roles of the gut microbiota and dietary phytochemicals in improving human health. Recent studies have reported that the human gut microbiota can be altered by dietary phytochemicals, including phenolics, carotenoids, and dietary fibers. In addition, both pathogenic and nonpathogenic bacteria show regulatory effects with phytochemicals, suggesting potential synergistic effects in the improvement of human gut health and prevention of chronic diseases. Recent Findings: Numerous studies have been conducted on gut microbial alterations induced by phytochemicals, such as phenolics and carotenoids. Butyrate, a short-chain fatty acid produced via bacterial fermentation in the colon, also shows a significantly beneficial effect in the maintenance of gut microbial homeostasis. However, the molecular mechanisms underlying the effects of diets and the interactions of the gut microorganisms remain poorly understood. The gut microbiome profile changes have been observed in chronic inflammation-induced diseases, including colitis, Crohn’s disease, immune dysfunction, colon cancer, obesity, and diabetes. The anti-inflammatory effects of dietary phytochemicals against these diseases may be partially mediated by the regulation of microbial profiles. The latest advances in biomedical technology, such as next-generation sequencing (NGS), and continuous cost reduction associated with these technologies have enabled researchers to perform an ever-increasing number of large-scale, high-throughput computational analyses to elucidate the potential mechanism of phytochemical–microbiome interactions. Summary: Information obtained from these studies may provide valuable insights to guide future clinical research for the development of therapeutics, botanicals, and drug efficacy testing, many of which will be discussed in this review.

AB - Purpose of Review: In this review, we discuss the roles of the gut microbiota and dietary phytochemicals in improving human health. Recent studies have reported that the human gut microbiota can be altered by dietary phytochemicals, including phenolics, carotenoids, and dietary fibers. In addition, both pathogenic and nonpathogenic bacteria show regulatory effects with phytochemicals, suggesting potential synergistic effects in the improvement of human gut health and prevention of chronic diseases. Recent Findings: Numerous studies have been conducted on gut microbial alterations induced by phytochemicals, such as phenolics and carotenoids. Butyrate, a short-chain fatty acid produced via bacterial fermentation in the colon, also shows a significantly beneficial effect in the maintenance of gut microbial homeostasis. However, the molecular mechanisms underlying the effects of diets and the interactions of the gut microorganisms remain poorly understood. The gut microbiome profile changes have been observed in chronic inflammation-induced diseases, including colitis, Crohn’s disease, immune dysfunction, colon cancer, obesity, and diabetes. The anti-inflammatory effects of dietary phytochemicals against these diseases may be partially mediated by the regulation of microbial profiles. The latest advances in biomedical technology, such as next-generation sequencing (NGS), and continuous cost reduction associated with these technologies have enabled researchers to perform an ever-increasing number of large-scale, high-throughput computational analyses to elucidate the potential mechanism of phytochemical–microbiome interactions. Summary: Information obtained from these studies may provide valuable insights to guide future clinical research for the development of therapeutics, botanicals, and drug efficacy testing, many of which will be discussed in this review.

KW - Chronic diseases

KW - Human health

KW - Microbiota

KW - Phytochemicals

UR - http://www.scopus.com/inward/record.url?scp=85071263757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071263757&partnerID=8YFLogxK

U2 - 10.1007/s40495-019-00196-3

DO - 10.1007/s40495-019-00196-3

M3 - Review article

VL - 5

SP - 332

EP - 344

JO - Current Pharmacology Reports

JF - Current Pharmacology Reports

SN - 2198-641X

IS - 5

ER -